Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D002108:Ceruletide / Q000494:pharmacology*; D002766:Cholecystokinin / Q000494:pharmacology*; D004298:Dopamine / Q000502:physiology*; D008297:Male; D009474:Neurons / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains
D002108:Ceruletide; D002766:Cholecystokinin; D001058:Apomorphine; D004298:Dopamine